Prostate-specific antigen response to androgen deprivation therapy in the neoadjuvant setting for high-risk prostate adenocarcinoma (PIRANHA): Pooled analysis of two randomized clinical trials

- Nikitas, John, Ong, Wee Loon, Carrier, Nathalie, Romero, Tahmineh, Millar, Jeremy, Steinberg, Michael L., Rettig, Matthew B., Boutros, Paul C., Reiter, Robert, Nickols, Nicholas G., Valle, Luca, McGuire, Sean E., Spratt, Daniel E., Souhami, Luis, Roy, Soumyajit, Martin, Jarad M., Joseph, David, Nabid, Abdenour, Kishan, Amar U.

Analysis of Rates of Completion, Delays, and Participant Recruitment in Randomized Clinical Trials in Surgery

- Shadbolt, Cade, Naufal, Elise, Choong, Peter, Dowsey, Michelle, Bunzli, Samantha, Price, Veronique, Rele, Siddharth, Schilling, Chris, Thuraisingam, Sharmala, Lohmander, L. Stefan, Balogh, Zsolt J., Clarke, Philip

Evaluation of Hypofractionated Radiation Therapy Use and Patient-Reported Outcomes in Men with Nonmetastatic Prostate Cancer in Australia and New Zealand

- Pryor, David I., Martin, Jarad M., Syed, Farhan, Hayden, Amy J., Turner, Sandra L., Papa, Nathan, Millar, Jeremy L., Day, Heather, Ong, Wee Loon, Skala, Marketa, Fitzgerald, Liesel M., Hindson, Benjamin, Higgs, Braden, O'Callaghan, Michael E.

Standardized assessment of adverse events in rheumatology clinical trials: Summary of the OMERACT 7 Drug Safety Module update

- Lassere, M. N. D., Johnson, Kent R., Boers, M., Carlton, K., Day, R. O., de Wit, M., Edwards, I. R., Fries, J. F., Furst, D. E., Kirwan, J. R., Tugwell, P. S., Woodworth, T. G., Brooks, P. M.